Clinical manifestations are complex and often involve multiple systems. Early identification and standardised clinical care are essential for improving prognosis. The diagnosis of this disease requires a comprehensive assessment platform including clinical manifestations, imaging, laboratory testing and pathological activation.
A team of authoritative experts at home and abroad can assist in providing accurate diagnosis and treatment. Treatment and management of ClJ manifestations require individual development, typically including drug therapy, rehabilitation interventions, and regular follow-up management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult-to-treat genetic metabolic diseases have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, according to changes in the course of the disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of CblJ disease. The platform serves a team of domestic and foreign experts in the field of genetic metabolism connected to the China International Medical Service System, providing patients with the following services: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.